Annual ROE
17.39%
+22.15%+465.34%
December 31, 2022
Summary
- As of February 8, 2025, EGRX annual return on equity is 17.39%, with the most recent change of +22.15% (+465.34%) on December 31, 2022.
- During the last 3 years, EGRX annual ROE has risen by +8.97% (+106.53%).
- EGRX annual ROE is now -89.15% below its all-time high of 160.22%, reached on September 30, 2012.
Performance
EGRX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
4.99%
+6.14%+533.91%
June 30, 2023
Summary
- As of February 8, 2025, EGRX quarterly return on equity is 4.99%, with the most recent change of +6.14% (+533.91%) on June 30, 2023.
- Over the past year, EGRX quarterly ROE has dropped by -6.29% (-55.76%).
- EGRX quarterly ROE is now -94.09% below its all-time high of 84.39%, reached on March 31, 2017.
Performance
EGRX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
EGRX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +465.3% | -55.8% |
| 3 y3 years | +106.5% | +297.2% |
| 5 y5 years | -44.7% | -70.5% |
EGRX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +465.3% | -73.2% | +208.0% |
| 5 y | 5-year | at high | +465.3% | -73.2% | +208.0% |
| alltime | all time | -89.2% | +105.9% | -94.1% | +101.0% |
Eagle Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | 4.99%(-533.9%) |
| Mar 2023 | - | -1.15%(-107.1%) |
| Dec 2022 | 17.39%(-465.3%) | 16.26%(+60.0%) |
| Sep 2022 | - | 10.16%(-9.9%) |
| Jun 2022 | - | 11.28%(-39.4%) |
| Mar 2022 | - | 18.60%(-502.6%) |
| Dec 2021 | -4.76%(-172.5%) | -4.62%(-253.0%) |
| Sep 2021 | - | 3.02%(-69.4%) |
| Jun 2021 | - | 9.86%(+25.1%) |
| Mar 2021 | - | 7.88%(+18.9%) |
| Dec 2020 | 6.57%(-22.0%) | 6.63%(+140.2%) |
| Sep 2020 | - | 2.76%(-209.1%) |
| Jun 2020 | - | -2.53%(-280.7%) |
| Mar 2020 | - | 1.40%(-83.1%) |
| Dec 2019 | 8.42%(-55.1%) | 8.29%(-43.8%) |
| Sep 2019 | - | 14.74%(-38.1%) |
| Jun 2019 | - | 23.82%(+11.3%) |
| Mar 2019 | - | 21.40%(+20.4%) |
| Dec 2018 | 18.77% | 17.77%(+13.6%) |
| Sep 2018 | - | 15.64%(-7.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | 16.94%(-7.8%) |
| Mar 2018 | - | 18.38%(-41.0%) |
| Dec 2017 | 31.45%(-53.4%) | 31.15%(-52.7%) |
| Sep 2017 | - | 65.89%(-5.0%) |
| Jun 2017 | - | 69.38%(-17.8%) |
| Mar 2017 | - | 84.39%(+13.4%) |
| Dec 2016 | 67.44%(+1517.3%) | 74.42%(+183.7%) |
| Sep 2016 | - | 26.23%(+664.7%) |
| Jun 2016 | - | 3.43%(-117.9%) |
| Mar 2016 | - | -19.19%(-705.4%) |
| Dec 2015 | 4.17%(-104.1%) | 3.17%(-153.1%) |
| Sep 2015 | - | -5.97%(+16.8%) |
| Jun 2015 | - | -5.11%(-218.8%) |
| Mar 2015 | - | 4.30%(-106.3%) |
| Dec 2014 | - | -68.16%(-7.1%) |
| Sep 2014 | -102.29%(-65.3%) | -73.36%(+95.5%) |
| Jun 2014 | - | -37.53%(+26.4%) |
| Mar 2014 | - | -29.68%(-93.8%) |
| Dec 2013 | - | -482.24%(+63.8%) |
| Sep 2013 | -294.45%(-283.8%) | -294.45% |
| Sep 2012 | 160.22% | - |
FAQ
- What is Eagle Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals annual ROE year-on-year change?
- What is Eagle Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals quarterly ROE year-on-year change?
What is Eagle Pharmaceuticals annual return on equity?
The current annual ROE of EGRX is 17.39%
What is the all time high annual ROE for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high annual return on equity is 160.22%
What is Eagle Pharmaceuticals annual ROE year-on-year change?
Over the past year, EGRX annual return on equity has changed by +22.15% (+465.34%)
What is Eagle Pharmaceuticals quarterly return on equity?
The current quarterly ROE of EGRX is 4.99%
What is the all time high quarterly ROE for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high quarterly return on equity is 84.39%
What is Eagle Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, EGRX quarterly return on equity has changed by -6.29% (-55.76%)